News Category Cellect ArchiveQuoin Year None202220212020201920182017 Quoin Pharmaceuticals Announces Dosing of First Patient in Clinical Trial in Netherton Syndrome Dec 13, 2022 PDF Version Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2022 Financial Results Nov 10, 2022 PDF Version Quoin Pharmaceuticals Announces Updated Timing of Third Quarter 2022 Corporate Update Conference Call to be held on Thursday November 10th Nov 03, 2022 PDF Version Quoin Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10th Nov 01, 2022 PDF Version Quoin Pharmaceuticals Announces Plans to Initiate a Second Clinical Trial in Netherton Syndrome Patients Oct 18, 2022 PDF Version Quoin Pharmaceuticals Establishes Patient Specific Website for Ongoing Netherton Syndrome Clinical Study Sep 13, 2022 PDF Version Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results Aug 18, 2022 PDF Version Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th Aug 11, 2022 PDF Version Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering Aug 09, 2022 PDF Version Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering Aug 05, 2022 PDF Version Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 23
Quoin Pharmaceuticals Announces Dosing of First Patient in Clinical Trial in Netherton Syndrome Dec 13, 2022 PDF Version
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2022 Financial Results Nov 10, 2022 PDF Version
Quoin Pharmaceuticals Announces Updated Timing of Third Quarter 2022 Corporate Update Conference Call to be held on Thursday November 10th Nov 03, 2022 PDF Version
Quoin Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10th Nov 01, 2022 PDF Version
Quoin Pharmaceuticals Announces Plans to Initiate a Second Clinical Trial in Netherton Syndrome Patients Oct 18, 2022 PDF Version
Quoin Pharmaceuticals Establishes Patient Specific Website for Ongoing Netherton Syndrome Clinical Study Sep 13, 2022 PDF Version
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results Aug 18, 2022 PDF Version
Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th Aug 11, 2022 PDF Version
Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering Aug 05, 2022 PDF Version